Prognosis of PCI in the Older Adult Population: Outcomes From the Multicenter Prospective e-ULTIMASTER Registry
- PMID: 39131453
- PMCID: PMC11308062
- DOI: 10.1016/j.jscai.2022.100442
Prognosis of PCI in the Older Adult Population: Outcomes From the Multicenter Prospective e-ULTIMASTER Registry
Abstract
Background: Older adult patients undergoing percutaneous coronary intervention (PCI) are usually excluded from clinical trials. This study aimed to assess 1-year clinical outcomes in patients aged >80 years.
Methods: This all-comer registry included patients who underwent PCI using the Ultimaster stent. Primary clinical endpoint was target lesion failure (TLF), a composite of cardiac death (CD), target vessel-related myocardial infarction (TV-MI), or clinically indicated target lesion revascularization (CD-TLR).
Results: In total, 3286 (8.8%) patients aged ≥80 years were compared with 33,912 patients aged <80 years. The older adult patients included more women, had more comorbidities and exhibited more complex coronary anatomy. The incidence of TLF was higher in the older adult group (5.6% vs 3.0%, P < .0001), as well as for all-cause mortality (6.2% vs 1.7%, P < .0001), CD (3.3% vs 1.1%, P < .0001), and TV-MI (1.7% vs 0.8%, P < .0001), but not for CD-TLR (1.9% vs 1.7%, P = .15). After the inverse propensity score weighted analysis, aged ≥80 years was associated with increased risk of TLF (HR, 1.42; 95% CI, 1.22-1.66; P < .0001), CD (HR, 1.67; 95% CI, 1.136-2.06; P < .0001), and TV-MI (HR, 1.66; 95% CI, 1.24-2.24; P < .001) but not for CD-TLR (HR, 1.10; 95% CI, 0.85-1.43; P = .45).
Conclusion: Older adult patients had a higher incidence of TLF, CD, and TV-MI but with no difference in the incidence of recurrent revascularization or stent thrombosis. Although PCI in older adults is relatively safe, higher rates of cardiac events should be considered.
Keywords: age; coronary artery disease; elderly; older adults; outcome; stent; vascular disease.
© 2022 The Author(s).
Figures






Similar articles
-
Prognosis of PCI in AMI setting in the elderly population: Outcomes from the multicenter prospective e-ULTIMASTER registry.Clin Cardiol. 2022 Dec;45(12):1211-1219. doi: 10.1002/clc.23902. Epub 2022 Sep 7. Clin Cardiol. 2022. PMID: 36072999 Free PMC article.
-
[Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions: 5-year results of the TARGET Ⅱ trial].Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Jul 24;46(7):523-528. doi: 10.3760/cma.j.issn.0253-3758.2018.07.004. Zhonghua Xin Xue Guan Bing Za Zhi. 2018. PMID: 30032542 Clinical Trial. Chinese.
-
Impact of peripheral artery disease on prognosis after percutaneous coronary intervention: Outcomes from the multicenter prospective e-ULTIMASTER registry.Atherosclerosis. 2022 Mar;344:71-77. doi: 10.1016/j.atherosclerosis.2022.01.007. Epub 2022 Jan 25. Atherosclerosis. 2022. PMID: 35135696
-
Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.JACC Cardiovasc Interv. 2013 Sep;6(9):905-13. doi: 10.1016/j.jcin.2013.04.017. Epub 2013 Aug 14. JACC Cardiovasc Interv. 2013. PMID: 23954063
-
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry).Catheter Cardiovasc Interv. 2020 Aug;96(2):255-265. doi: 10.1002/ccd.28694. Epub 2020 Jan 6. Catheter Cardiovasc Interv. 2020. PMID: 31905259
Cited by
-
Shorter Dual Antiplatelet Therapy for Older Adults After Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis.JAMA Netw Open. 2024 Mar 4;7(3):e244000. doi: 10.1001/jamanetworkopen.2024.4000. JAMA Netw Open. 2024. PMID: 38546647 Free PMC article.
-
Intravascular lithotripsy for the treatment of calcified coronary lesions in individuals of advanced age: a post-hoc analysis of the multicentre, prospective BENELUX-IVL study.EClinicalMedicine. 2025 Jul 4;85:103342. doi: 10.1016/j.eclinm.2025.103342. eCollection 2025 Jul. EClinicalMedicine. 2025. PMID: 40686682 Free PMC article.
-
Sex Differences in Patients Undergoing Left Main Stem Percutaneous Coronary Intervention for Stable Angina: Data From a National Registry.J Am Heart Assoc. 2024 Nov 19;13(22):e036569. doi: 10.1161/JAHA.124.036569. Epub 2024 Nov 15. J Am Heart Assoc. 2024. PMID: 39547994 Free PMC article.
-
Predictors of major adverse cardiac and cerebrovascular events after percutaneous coronary intervention in older adults: a systematic review and meta-analysis.BMC Geriatr. 2024 Apr 12;24(1):337. doi: 10.1186/s12877-024-04896-4. BMC Geriatr. 2024. PMID: 38609875 Free PMC article.
-
Bleeding Risk in Elderly Patients Undergoing Percutaneous Coronary Intervention: A Comprehensive Review.J Clin Med. 2025 Feb 12;14(4):1194. doi: 10.3390/jcm14041194. J Clin Med. 2025. PMID: 40004725 Free PMC article. Review.
References
-
- Tsounis D., Deftereos S., Bouras G., et al. High sensitivity troponin in cardiovascular disease. Is there more than a marker of myocardial death? Curr Top Med Chem. 2013;13(2):201–215. - PubMed
-
- Renilla A., Barreiro M., Barriales V., Torres F., Alvarez P., Lambert J.L. Management and risk factors for mortality in very elderly patients with acute myocardial infarction. Geriatr Gerontol Int. 2013;13(1):146–151. - PubMed
-
- Trucil D.E., Lundebjerg N.E., Busso D.S. RESEARCH When it comes to older adults, language matters and is changing: American Geriatrics Society update on reframing aging style changes. J Am Geriatr Soc. 2021;69(1):265–267. - PubMed
-
- Sawant A.C., Josey K., Plomondon M.E., et al. Temporal trends, complications, and predictors of outcomes among nonagenarians undergoing percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. JACC Cardiovasc Interv. 2017;10(13):1295–1303. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous